Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enovix (ENVX) Research & Development (2020 - 2025)

Enovix (ENVX) has disclosed Research & Development for 6 consecutive years, with $28.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 25.15% year-over-year to $28.1 million, compared with a TTM value of $110.3 million through Dec 2025, down 11.38%, and an annual FY2025 reading of $110.3 million, down 11.38% over the prior year.
  • Research & Development was $28.1 million for Q4 2025 at Enovix, roughly flat from $28.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $48.8 million in Q1 2024 and bottomed at $5.6 million in Q1 2021.
  • Average Research & Development over 5 years is $22.8 million, with a median of $24.0 million recorded in 2023.
  • The sharpest move saw Research & Development surged 127.79% in 2022, then tumbled 46.85% in 2025.
  • Year by year, Research & Development stood at $10.3 million in 2021, then soared by 53.65% to $15.8 million in 2022, then skyrocketed by 118.5% to $34.6 million in 2023, then plummeted by 35.13% to $22.4 million in 2024, then grew by 25.15% to $28.1 million in 2025.
  • Business Quant data shows Research & Development for ENVX at $28.1 million in Q4 2025, $28.2 million in Q3 2025, and $28.1 million in Q2 2025.